Reid Robison, MD, MBA

home / authors / reid-robison-md-mba

Dr Robison is chief medical officer of Novamind; medical director for the Center for Change; and coordinating investigator for the Multidisciplinary Association for Psychedelic Studies’ phase 2 clinical trial examining MDMA-assisted psychotherapy for the treatment of eating disorders.


© 2024 MJH Life Sciences

All rights reserved.